88%
Finnrick rating
#8 of 186 Tirzepatide vendors
10 of 10 classifiable tests passed
natural 100% · customers 4.8★ (6)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Huayi Biotechnology's tirzepatide shows a low-concern reliability profile under Purity focus, with consistent identity and 99.5%+ purity results. Review fill spread and batch documentation: one sample was 23% underfilled and many lacked批

methodology →
vendor intelligence report
Vendor Intelligence Report: Huayi Biotechnology

Huayi’s footprint splits between a closed Shoplazza storefront and an active Shop910-backed domain with cloaking and special-payment features. The report traces Tongkang-linked certificates, SV-branded vials, and review redirects while the true operator remains unresolved.

26 pages7 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
92%
7
2
Tirzepatideselected
$0.70
88%
10
3
Retatrutide
$1.04
87%
21
4
BPC-157
$0.78
54%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Sept 2025: 72%4 Sept 2025: 76%18 Sept 2025: 78%7 Jan 2026: 83%26 Jan 2026: 85%26 Jan 2026: 86%11 Feb 2026: 86%1 Mar 2026: 86%18 Mar 2026: 87%15 Jun 2026: 88%9 Aug 2026: current 88%72%83%88%Sep 25Aug 26
Showing Tirzepatide tests only
Huayi Biotechnology Tirzepatide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
15 Jun 2026Pass
Tested
lab nameView COA
18 Mar 2026Pass
Tested
lab nameView COA
1 Mar 2026Pass
Tested
lab nameView COA
11 Feb 2026Pass
Tested
lab nameView COA
26 Jan 2026Pass
Tested
lab nameView COA
26 Jan 2026Pass
Tested
lab nameView COA
7 Jan 2026Pass
Tested
lab nameView COA
18 Sep 2025Pass
Tested
lab nameView COA
4 Sep 2025Pass
Tested
lab nameView COA
1 Sep 2025Pass
Tested
lab nameView COA

About Huayi Biotechnology test results from Finnrick

Huayi Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 42 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Huayi Biotechnology peptides in this dataset are Tirzepatide (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 42 recent tests.

Corrections
No corrections.